Rockefeller Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Rockefeller Capital Management's VCYT Position: Q2 2026 in Review
Rockefeller Capital Management increased its Veracyte (VCYT) stake by 16% in Q2 2026, buying an estimated $15.3K and bringing the position to 2,666 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2732.
Rockefeller Capital Management first reported a position in VCYT in Q1 2020 and has held it in 16 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Rockefeller Capital Management held 2,666 shares of Veracyte worth $157K as of Q2 2026.
- Rockefeller Capital Management bought 364 Veracyte shares in Q2 2026, an estimated $15.3K.
- Veracyte made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2732 holding.
- Rockefeller Capital Management first reported a position in Veracyte in Q1 2020 and has held it in 16 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.